SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about trading window closure

27 Mar 2025 Evaluate
Sun Pharma Advanced Research Company has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (the CoC), the Trading Window for trading in shares of the Company shall remain closed with effect from Tuesday, April 1, 2025 till 48 hours after the declaration of Audited Financial Results of the Company for the financial year ended March 31, 2025. The date of Board Meeting to approve the Audited Financial Results of the Company for the financial year ended March 31, 2025 shall be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

219.65 1.45 (0.66%)
06-Aug-2026 12:11 View Price Chart
Peers
Company Name CMP
Indegene 546.80
Syngene Internatl. 400.00
CMS Info Systems 277.85
JITF Infralogistics 338.20
Sagility 43.99
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: